Recon: US begins Medicare coverage review for Biogen’s Aduhelm; EU efforts to review Sputnik stymied by data gaps
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy